| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/10717544.2017.1337825 |
| P698 | PubMed publication ID | 28633547 |
| P50 | author | Xin-Fu Zhou | Q47432909 |
| Sanjay Garg | Q37831335 | ||
| P2093 | author name string | Ankit Parikh | |
| Chun Chuan Tan | |||
| Krishna Kathawala | |||
| P2860 | cites work | Quality-by-design based development of a self-microemulsifying drug delivery system to reduce the effect of food on Nelfinavir mesylate. | Q51289561 |
| Effects of non-ionic surfactants on cytochrome P450-mediated metabolism in vitro. | Q52899360 | ||
| Improved Oral Bioavailability Using a Solid Self-Microemulsifying Drug Delivery System Containing a Multicomponent Mixture Extracted from Salvia miltiorrhiza. | Q53123969 | ||
| Development of a solidified self-microemulsifying drug delivery system (S-SMEDDS) for atorvastatin calcium with improved dissolution and bioavailability. | Q53709355 | ||
| Preparation of pH-sensitive poly(vinyl alcohol-g-methacrylic acid) and poly(vinyl alcohol-g-acrylic acid) hydrogels by gamma ray irradiation and their insulin release behavior | Q57340863 | ||
| β-amyloid fibrils in Alzheimer disease are not inert when bound to copper ions but can degrade hydrogen peroxide and generate reactive oxygen species. | Q39007098 | ||
| Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects | Q39284270 | ||
| Preparation and bioavailability assessment of SMEDDS containing valsartan | Q39922643 | ||
| Optimization, ex vivo permeation, and stability study of lipid nanocarrier loaded gelatin capsules for treatment of intermittent claudication | Q41891300 | ||
| Density functional theory (DFT) study of edaravone derivatives as antioxidants | Q41915708 | ||
| Formulation development and optimization using nanoemulsion technique: a technical note | Q41989945 | ||
| Development of self-microemulsifying drug delivery system and solid-self-microemulsifying drug delivery system of telmisartan | Q43025539 | ||
| Enhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in rats | Q44247758 | ||
| Efficacy of edaravone, a free radical scavenger, on left ventricular function and structure in diabetes mellitus | Q44459353 | ||
| Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part I. Formulation development, statistical optimization, and in vitro characterization. | Q44575462 | ||
| Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta | Q44724513 | ||
| Solid self-microemulsifying drug delivery system of ritonavir | Q45105785 | ||
| Evaluation of edaravone against radiation-induced oral mucositis in mice | Q46749262 | ||
| Solid self-emulsifying drug delivery system (S-SEDDS) for improved dissolution rate of fenofibrate | Q46980214 | ||
| Development of a novel oral delivery system of edaravone for enhancing bioavailability | Q47851842 | ||
| Formulation and statistical optimization of self-microemulsifying drug delivery system of eprosartan mesylate for improvement of oral bioavailability. | Q48139510 | ||
| Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform | Q48196138 | ||
| Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies | Q48321971 | ||
| Free radicals and antioxidants in normal physiological functions and human disease | Q21710698 | ||
| Exemestane loaded self-microemulsifying drug delivery system (SMEDDS): development and optimization | Q24610012 | ||
| Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus | Q24610099 | ||
| Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy | Q26780502 | ||
| Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems | Q30318472 | ||
| Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS). | Q33573478 | ||
| A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? | Q33938450 | ||
| Modeling and comparison of dissolution profiles | Q34215811 | ||
| Preparation and evaluation of SEDDS and SMEDDS containing carvedilol | Q34459102 | ||
| Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides | Q34519807 | ||
| Co-delivery of natural metabolic inhibitors in a self-microemulsifying drug delivery system for improved oral bioavailability of curcumin | Q34554669 | ||
| Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems. | Q34631955 | ||
| Preparation and evaluation of self-microemulsifying drug delivery system of oridonin | Q34744529 | ||
| Hydroxypropyl-sulfobutyl-β-cyclodextrin improves the oral bioavailability of edaravone by modulating drug efflux pump of enterocytes. | Q35060006 | ||
| Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits | Q35549137 | ||
| Role of hydrogen peroxide in the aetiology of Alzheimer's disease: implications for treatment. | Q35666080 | ||
| Characterization and evaluation of a self-microemulsifying drug delivery system containing tectorigenin, an isoflavone with low aqueous solubility and poor permeability | Q36304680 | ||
| A Self-microemulsifying Drug Delivery System (SMEDDS) for a Novel Medicative Compound Against Depression: a Preparation and Bioavailability Study in Rats | Q36360531 | ||
| Inflammation and human cerebral aneurysms: current and future treatment prospects. | Q37414772 | ||
| Beyond free radical scavenging: Beneficial effects of edaravone (Radicut) in various diseases (Review). | Q38042627 | ||
| Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead | Q38199539 | ||
| Nanoformulation and encapsulation approaches for poorly water-soluble drug nanoparticles. | Q38687039 | ||
| The Effects of Pharmaceutical Excipients on Gastrointestinal Tract Metabolic Enzymes and Transporters-an Update | Q38835634 | ||
| Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: In vitro pulmonary deposition and cytotoxicity. | Q38899811 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | edaravone | Q335099 |
| P304 | page(s) | 962-978 | |
| P577 | publication date | 2017-11-01 | |
| P1433 | published in | Drug Delivery | Q5308838 |
| P1476 | title | Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation | |
| P478 | volume | 24 |
| Q89146974 | Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma |
| Q57181453 | Curcumin-loaded self-nanomicellizing solid dispersion system: part I: development, optimization, characterization, and oral bioavailability |
| Q91909936 | Edaravone reduces oxidative stress and intestinal cell apoptosis after burn through up-regulating miR-320 expression |
| Q50061295 | Self-Nanoemulsifying Drug Delivery Systems Containing Plantago lanceolata-An Assessment of Their Antioxidant and Antiinflammatory Effects. |
| Q55686117 | Self-nanomicellizing solid dispersion of edaravone: part I – oral bioavailability improvement. |
| Q60706687 | Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer's disease model |
| Q88437167 | Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics |
Search more.